Allena Pharmaceuticals (ALNA) Names Mark J. Fitzpatrick to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Allena Pharmaceuticals (ALNA) Names Mark J. Fitzpatrick to Board

Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors

April 7, 2021 8:01 AM EDT

NEWTON, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, today announced the appointment of Mark J. Fitzpatrick to its board of directors.

Mark is an experienced industry executive, who has led financial strategy at biopharmaceutical companies across all stages of development, said Louis Brenner, M.D., President and Chief Executive Officer of Allena Pharmaceuticals. His extensive experience working with late-stage, rare disease... More